Click to Share
 

Filter News
Show All Results
News By Country
News By Tag
Oligonucleotide Remove


July 2016
TuMoSuSaFrThWe
26252423222120

Public Company News

Business Press Releases

Oligonucleotide Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

12515658
By SMi Group
Emerging oligonucleotide therapeutics presented in two exclusive keynote addresses at SMi's 7th annual RNA Conference next February in London.
12349466
By Mary Ann Liebert, Inc., publishers
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc, (914) 740-2100, kruehle@liebertpub.com Splice-Switching Oligonucleotide Therapeutics Is Promising New Method for Editing Gene Transcripts New Rochelle, NY—In splice-switching, an innovative therapeutic...
12345903
By Mary Ann Liebert, Inc., publishers
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc, (914) 740-2100, kruehle@liebertpub.com Industry Group Releases Safety Testing Recommendations for Oligonucleotide-Based Therapeutics New Rochelle, NY—Novel oligonucleotide-based drugs in development offer...
By BIOO SCIENTIFIC
Bioo Scientific, an Austin, TX-based biotechnology company was honored yesterday with the 2013 General Motors Technology Award for Small Businesses at the 13th Annual Greater Austin Business Awards.

All Press Releases

12515658
By SMi Group
Emerging oligonucleotide therapeutics presented in two exclusive keynote addresses at SMi's 7th annual RNA Conference next February in London.
By Mary Ann Liebert, Inc., publishers
Therapeutic oligonucleotide analogs represent a new and promising family of drugs that act on nucleic acid targets such as RNA or DNA; however, their effectiveness has been limited due to difficulty crossing the cell membrane.
12349466
By Mary Ann Liebert, Inc., publishers
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc, (914) 740-2100, kruehle@liebertpub.com Splice-Switching Oligonucleotide Therapeutics Is Promising New Method for Editing Gene Transcripts New Rochelle, NY—In splice-switching, an innovative therapeutic...
12345903
By Mary Ann Liebert, Inc., publishers
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc, (914) 740-2100, kruehle@liebertpub.com Industry Group Releases Safety Testing Recommendations for Oligonucleotide-Based Therapeutics New Rochelle, NY—Novel oligonucleotide-based drugs in development offer...
By BIOO SCIENTIFIC
Bioo Scientific, an Austin, TX-based biotechnology company was honored yesterday with the 2013 General Motors Technology Award for Small Businesses at the 13th Annual Greater Austin Business Awards.
By TriLink BioTechnologies, Inc.
Dr. Gerald Zon, noted scientist in the field of nucleic acid research launched a new blog in conjunction with TriLink Biotechnologies. The blog, Zone In with Zon (zon.trilinkbiotech.com), focuses on what's trending in the field of nucleic acids.
12084947
By Mary Ann Liebert, Inc., publishers
By targeting the specific mutation that causes the hereditary neuromuscular disease myotonic dystrophy, it is possible to neutralize the mutant RNA toxicity and minimize or even eliminate the disabling symptoms of the disease.
By Link Technologies Ltd
AIC to distribute Link’s specialist oligonucleotide modifiers in North America
By Alto Marketing
New survey results highlight the quality of Link’s custom oligo precursors and exceptional customer service
By TriLink BioTechnologies, Inc.
The National Institutes of Health recently awarded TriLink BioTechnologies, Inc. (TriLink) a Phase II SBIR Grant of approximately $725,000 to continue their work on developing reagents to enhance the specificity of DNA ligase.
By Biosearch Technologies, Inc
Biosearch Technologies, Inc. today announced that on September 16th, 2009, the company licensed from Roche Molecular Systems (Roche), a family of patents covering practice of the 5’ Nuclease process.
By Dan Dunlop
Dr. Hans Westenburg, a senior scientist of structural characterization and analysis at Catalent Pharma Solutions, will present this month at the TIDES 2009 Conference to be held in Las Vegas, NV, May 17-20, 2009.

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share